• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Psychol . Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

tetano

Editor, Senior Moderator
BMC Psychol


. 2024 Apr 26;12(1):236.
doi: 10.1186/s40359-024-01740-7. Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations

Antonio de Pádua Serafim[SUP] 1 [/SUP], Fabiana Saffi[SUP] 2 [/SUP], Amanda Rafaella A Soares[SUP] 2 [/SUP], Alessandra Mara Morita[SUP] 2 [/SUP], Mariana Medeiros Assed[SUP] 3 [/SUP], Sandro de Toledo[SUP] 4 [/SUP], Cristiana C A Rocca[SUP] 2 [/SUP], Ricardo S S Durães[SUP] 3 4 [/SUP]



Affiliations
Abstract

Background: Studying individuals with varying symptoms, from mild to severe, can provide valuable insights into the spectrum of cognitive outcomes after COVID-19. We investigated the cognitive performance of adults who recovered from the novel coronavirus disease (COVID-19) without prior cognitive complaints, considering mild (not hospitalized), moderate (ward), and severe (intensive care unit) symptoms.
Methods: This cross-sectional study included 302 patients who recovered from COVID-19 (mild, n = 102; moderate, n = 102; severe, n = 98). We assessed intellectual quotient (IQ), attention, memory, processing speed, visual-constructive ability, as well as symptoms of depression, anxiety, and stress, at least eighteen months after infection. The mean length of hospitalization was M[SUB]days[/SUB]=8.2 (SD = 3.9) and M[SUB]days[/SUB]=14.4 (SD = 8.2) in the moderate and severe groups, respectively.
Results: Cognitive difficulties were present in all three groups: mild (n = 12, 11.7%), moderate (n = 40, 39.2%), and severe (n = 48, 48.9%). Using Multinomial Logistic Regression and considering the odds ratio, our results indicated that a one-point increase in sustained attention, visual memory, and working memory might decrease the odds of being categorized in the severe group by 20%, 24%, and 77%, respectively, compared to the mild group.
Conclusions: Our findings provide empirical evidence regarding the long-term cognitive effects of COVID-19, particularly in individuals experiencing severe manifestations of the disease. We also highlighted the need for a comprehensive, multidimensional approach in rehabilitation programs to address the enduring cognitive impacts of COVID-19.

Keywords: COVID-19; Cognitive difficulties; Long COVID; Neuropsychological assessment.

 
Back
Top Bottom